These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24581)

  • 1. Interaction of human Clq with insoluble immunoglobulin aggregates.
    Lin TY; Fletcher DS
    Immunochemistry; 1978 Feb; 15(2):107-17. PubMed ID: 24581
    [No Abstract]   [Full Text] [Related]  

  • 2. Quantitation of immune complexes by competitive inhibition of binding of Clq to insoluble IgG aggregates.
    Fletcher DS; Lin TY
    J Immunol Methods; 1977; 15(1):39-45. PubMed ID: 845441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents.
    Arlaud GJ; Sim RB; Duplaa AM; Colomb MG
    Mol Immunol; 1979 Jul; 16(7):445-50. PubMed ID: 40870
    [No Abstract]   [Full Text] [Related]  

  • 4. Rat Clq: similarity to human Clq in functional and compositional properties.
    Höffken K; McLaughlin PJ; Price MR; Preston VE; Baldwin RW
    Immunochemistry; 1978 Jun; 15(6):409-12. PubMed ID: 700777
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of the interaction between the complement component Clq and immune complexes.
    Allan R; Rodrick M; Knobel HR; Isliker H
    Int Arch Allergy Appl Immunol; 1979; 58(2):140-8. PubMed ID: 33905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reaction between the isolated globular sub-units of the complement component C1q and IgG-complexes.
    Hughes-Jones NC; Gardner B
    Mol Immunol; 1979 Sep; 16(9):697-701. PubMed ID: 119162
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship between the binding ability and the rate of activation of the complement component C1.
    Folkerd EJ; Gardner B; Hughes-Jones NC
    Immunology; 1980 Sep; 41(1):179-85. PubMed ID: 7429549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of circulating antigen-antibody complexes by their inhibitory effect on the agglutination of IgG-coated particles by rheumatioid factor of Clq.
    Lurhuma AZ; Cambiaso CL; Masson PL; Heremans JF
    Clin Exp Immunol; 1976 Aug; 25(2):212-26. PubMed ID: 954232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of C1-inhibitor with the C1r and C1s subcomponents in human C1.
    Arlaud GJ; Reboul A; Sim RB; Colomb MG
    Biochim Biophys Acta; 1979 Jan; 576(1):151-62. PubMed ID: 760802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibronectin associated with Clq in a Clq isolation procedure.
    Anderson B; Entwistle R; Puyat L; Davis L; Schmid FR
    Immunol Commun; 1981; 10(8):687-96. PubMed ID: 6804372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C1 dissociation. Spontaneous generation in human serum of a trimer complex containing C1 inactivator, activated C1r, and zymogen C1s.
    Laurell AB; Mårtensson U; Sjöholm AG
    J Immunol; 1987 Dec; 139(12):4145-51. PubMed ID: 2826582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Co-operative interaction of subcomponents of the first component of complement with IgG: a functional defect of dimeric Facb from rabbit IgG.
    Okada M; Udaka K; Utsumi S
    Mol Immunol; 1985 Dec; 22(12):1399-406. PubMed ID: 3007976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The binding of human complement component C4 to antibody-antigen aggregates.
    Campbell RD; Dodds AW; Porter RR
    Biochem J; 1980 Jul; 189(1):67-80. PubMed ID: 6906229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Clq receptor site on immunoglobulin G.
    Burton DR; Boyd J; Brampton AD; Easterbrook-Smith SB; Emanuel EJ; Novotny J; Rademacher TW; van Schravendijk MR; Sternberg MJ; Dwek RA
    Nature; 1980 Nov; 288(5789):338-44. PubMed ID: 6776418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first complement component: evidence for an equilibrium between C1s free in serum and C1s bound in the C1 complex.
    Bartholomew RM; Esser AF
    J Immunol; 1977 Dec; 119(6):1916-22. PubMed ID: 915287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The binding and activation of the Clr-Cls subunit of the first component of human complement.
    Hughes-Jones NC; Gorick BD
    Mol Immunol; 1982 Sep; 19(9):1105-12. PubMed ID: 6292705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the first component of complement.
    Schumaker VN; Zavodszky P; Poon PH
    Annu Rev Immunol; 1987; 5():21-42. PubMed ID: 3036181
    [No Abstract]   [Full Text] [Related]  

  • 18. C1- inactivator: its efficiency as a regulator of classical complement pathway activation by soluble IgG aggregates.
    Doekes G; van Es LA; Daha MR
    Immunology; 1983 Jun; 49(2):215-22. PubMed ID: 6852866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heating at 56 degrees C does not eliminate immune complex-bound Clq.
    Teppo AM; Wager O
    Scand J Immunol; 1979; 10(5):431-5. PubMed ID: 545666
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Clq immunosorbent assay compared with thin-layer gel filtration for measuring IgG aggregates.
    Ahlstedt S; Hanson LA; Wadsworth C
    Scand J Immunol; 1976; 5(3):293-8. PubMed ID: 1273518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.